Advanced search×

Extracellular superoxide dismutase attenuates release of pulmonary hyaluronan from the extracellular matrix following bleomycin exposure

FEBS Lett 584(13):6 (2010) PMID 20493858 PMCID PMC2892677

The major pulmonary antioxidant enzyme involved in the protection of the lung interstitium from oxidative stress is extracellular superoxide dismutase (EC-SOD). It has been previously shown that EC-SOD knock-out mice are more susceptible to bleomycin-induced lung injury, however, the molecular mechanism(s) remains unclear. We report here that bleomycin-induced lung damage, in EC-SOD KO mice, is associated with increased hyaluronan release into alveolar fluid. Analysis of hyaluronan synthase gene expression and hyaluronan molecular weight distribution suggested that elevated levels of hyaluronan in the alveolar fluid are mostly due to its release from the interstitium. Our results indicate that EC-SOD attenuates bleomycin-induced pulmonary injury, at least in part, by preventing superoxide-mediated release of hyaluronan into alveolar space.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.febslet.2010.05.025
Version: za2963e q8za9 q8zbf q8zc8 q8zdd q8zed q8zfc q8zg8

Similar articles you may find interesting…

  1. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells.

    Med Oncol 29(1):10-5 (2012) PMID 21191671

    We performed an evaluation of the effects of UA on apoptosis in MCF-7 cells. UA was found to inhibit the proliferation of MCF-7 cells in a concentration and time-dependent manner. After treatment, UA-induced apoptosis was accompanied by a significant decrease in CyclinD1/CDK4 expression, which can b...
  2. Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.

    Pharmacogenomics 11(12):1637-47 (2010) PMID 21142906

    The 2010 US FDA-Drug Industry Association (DIA) Pharmacogenomics (PGx) Workshop follows a series that began in 2002 bringing together multidisciplinary experts spanning regulatory authorities, medical research, healthcare and industry. This report summarizes the 'Building PGx into Labels' sessions f...
  3. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia

    Cancer Genet Cytogenet 193(1):10 (2009) PMID 19602459

    We report unique patterns of copy number loss in samples with 9p21.3 (CDKN2A) deletion in the precursor B-cell ALL patients, compared with the precursor T-cell ALL patients. MIPs represent an attractive technology for identifying novel copy number aberrations, validating previously reported copy num...